Pradaxa (dagibatran) is a blood thinner made by Boehringer Ingelheim Pharmaceuitcals to treat patients suffering from atrial fibrillation and venous thromboembolism.
In venous thromboembolism, a person has a predisposition to developing blood clots in a vein, and atrial fibrillation is an irregular heartbeat. In both cases, a blood clot traveling to the heart or lungs could cause a fatal stroke or heart attack.
Pradaxa, a blood thinning agent, works by inhibiting clot formation in the body. When the body does not produce blood clots, health risks involving blood clots are lessened.
Pradaxa: Too Much of a Good Thing
Pradaxa works very well for most individuals when it comes to interfering with clot formation, thus helping individuals avoid clots and their related potential negative consequences. However, having thinned blood without the ability to clot is not always a good thing.
Sometimes, an internal bleed may develop, and because Pradaxa inhibits clotting, the body cannot stop the bleed with its usual clotting mechanism. Consequently, when a patient is taking Pradaxa and suffers an internal bleed, it can become devastating.
Internal bleeding, particularly gastrointestinal bleeding, is a particular concern for patients on Pradaxa. Because the bleeding is happening inside the body where the damage is not seen, it can be difficult to immediately address the concern. The bleeding may not be discovered until an obviously concerning symptom like coughing up blood or seeing blood in the urine or feces is apparent. Patients may miss subtler signs like headaches, dizziness, aches, pains and dark stools that indicate an internal bleed.
Since its release in 2010 until just a few months ago, there was no way for doctors to stop the internal bleeding once it started. There was no reversal agent or antidote available, like there was for Pradaxa’s predecessor, warfarin (Coumadin). Doctors had to simply wait out the effects of Pradaxa and try to mitigate any potential damage done by the internal bleeding.
Praxbind, the Pradaxa antidote released in October 2015, was developed by Boehringer Ingelheim to counteract and reverse any blood clotting effects due to the use of Pradaxa. Doctors and patients are hopeful that Pradaxa internal bleeding can now be safely controlled once it is identified.
Pradaxa Lawsuit Information
Moving forward, it is hoped that patients will not have to suffer the consequences of irreversible bleeds like they have in the past. With the development of Praxbind, potentially devastating outcomes may be avoided in the future.
However, for those already affected by severe gastrointestinal bleeding, the antidote was developed too late to help, and patients felt that there should have been adequate warning of the alleged potential safety issues associated with the lack of an antidote.
Many individuals and their families have filed lawsuits against Boehringer Ingelheim, manufacturer of Pradaxa, in an effort to warn other consumers about the dangers of the drug, as well as to urge the manufacturer to improve the drug’s safety.
So many lawsuits were filed that the Pradaxa lawsuits were consolidated into multidistrict litigations (MDL) to help facilitate the processing of the lawsuits. In May 2014, Boehringer Ingelheim, without admitting wrongdoing, agreed to settle over 4,000 lawsuits pending at the time, for a total of over $650 million.
Filing a Pradaxa Internal Bleeding Lawsuit
If you or a loved one has suffered from gastrointestinal bleeding or other severe side effects as a result of Pradaxa, you may be entitled to legal compensation. An experienced Pradaxa attorney can review your case at no charge and can assist you in determining if taking legal action by filing a Boehringer Ingelheim lawsuit is the right decision for you.
In general, Pradaxa lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Pradaxa attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Pradaxa class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Pradaxa Class Action Lawsuit Investigation
If you, or a loved one, experienced Pradaxa side effects, you may have a legal claim. Submit your information now for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which blood thinner did you or a loved one take at the time of the injury or injuries?*
- Pradaxa
- Xarelto
- Unknown
- Other
- Please check the injuries suffered:*
-
Death
-
Gastrointestinal Bleeding
-
Other Internal Bleeding
-
Cerebral Hemorrhaging
-
Unsure
-
None
-
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 24) {gformInitChosenFields(‘#input_24_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_24_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_24_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [24, 1]) } );
The post Pradaxa Linked to Serious Gastrointestinal Bleeding appeared first on Top Class Actions.
No comments:
Post a Comment